Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE.
Journal
Case reports in pulmonology
ISSN: 2090-6846
Titre abrégé: Case Rep Pulmonol
Pays: United States
ID NLM: 101585355
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
06
2020
revised:
21
08
2020
accepted:
04
09
2020
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
Asthma is one of the most common respiratory diseases encountered in clinical practice. Although the vast majority of asthmatics can be adequately controlled with inhaled steroids and other preventer medications, a small proportion remain uncontrolled. Anti-IgE treatment with omalizumab has been proposed in patients as a preferred approach in step 5 asthma therapy according to GINA guidelines. Although therapy with this molecule is approved for patients with atopic asthma and pretreatment serum IgE levels of 30-1500 only, there have been a few reports of its efficacy in subjects outside this reference IgE range. We report the case of a middle-aged lady with severe corticosteroid-dependent asthma and low serum IgE levels who was successfully treated with 9 months of omalizumab therapy. She gained good asthma control and was tapered off steroid use by the fifth month of therapy with omalizumab. The case report stresses the need for further investigation into expanding the spectrum of omalizumab usage in asthma beyond the current IgE suitability range.
Identifiants
pubmed: 33014501
doi: 10.1155/2020/8898454
pmc: PMC7520673
doi:
Types de publication
Case Reports
Langues
eng
Pagination
8898454Informations de copyright
Copyright © 2020 Divya R et al.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Chest. 2011 Jan;139(1):190-3
pubmed: 21208879
Chest. 2013 Feb 1;143(2):398-405
pubmed: 23505637
N Engl J Med. 1991 Oct 10;325(15):1067-71
pubmed: 1891008
Chest. 2013 Aug;144(2):411-419
pubmed: 23579324
Allergy Asthma Clin Immunol. 2011 May 24;7(1):9
pubmed: 21609447
J Asthma. 2013 Apr;50(3):296-301
pubmed: 23350994
Chest. 2006 Jul;130(1 Suppl):4S-12S
pubmed: 16840363
Arerugi. 2010 Nov;59(11):1572-9
pubmed: 21119303
J Allergy Clin Immunol. 2015 Dec;136(6):1476-1485
pubmed: 26518090
Allergy. 2009 Oct;64(10):1472-7
pubmed: 19393000
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618810192
pubmed: 30400762
J Asthma. 2012 Oct;49(8):839-42
pubmed: 22920591
J Bras Pneumol. 2011 Jul-Aug;37(4):567-70
pubmed: 21881749
Eur Respir J. 1996 Apr;9(4):636-42
pubmed: 8726924
Indian J Chest Dis Allied Sci. 2006 Jan-Mar;48(1):13-22
pubmed: 16482947
Thorax. 2014 Jan;69(1):94-6
pubmed: 23709757
Int Arch Allergy Immunol. 2010;152(1):71-4
pubmed: 19940508